Method for separating and measuring bepotastine besilate and potential genotoxic impurities thereof with HPLC (High Performance Liquid Chromatography) method
A technology of genotoxicity and benzenesulfonic acid, applied in the field of analytical chemistry, to achieve the effects of good specificity and repeatability, high sensitivity, and accurate and reliable inspection results
Active Publication Date: 2018-03-09
CHONGQING HUAPONT PHARMA
View PDF7 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0006] So far, no published method has been reported for the efficient separation and quantification of bepotastine besilate and its potential genotoxic impurities
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0048] Example 1 Method for Separating and Determining Bepotastine Besilate and Its Potential Genotoxic Impurities
[0049] Instrument: SHIMADZU LC-20A (Shimadzu, Japan)
[0050] Chromatographic column: use octadecylsilane bonded silica gel as filler (XB-C18 100mm×4.6mm, 3μm or equivalent performance chromatographic column
[0051] Mobile phase A: 0.1% phosphoric acid solution by volume
[0052] Mobile phase B: 0.1% by volume acidic acetonitrile solution, 0.1% by volume phosphoric acid
[0053] Flow rate: 1.0ml / min
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention belongs to the field of analytical chemistry, in particular to a method for separating and measuring bepotastine besilate and potential genotoxic impurities thereof with a HPLC (High Performance Liquid Chromatography) method. According to the method, an adopted chromatographic column is characterized in that octadecylsilane chemically bonded silica is taken as a filler, a flowing phase A and a flowing phase B are adopted for performing gradient elution, and enter a detector for detecting; the potential genotoxic impurities includes ethyl benzenesulfonate and isopropyl benz-enesulfonate; the flowing phase A is a phosphoric acid solution, and the flowing phase B is an acidic acetonitrile solution. By adopting the method, the contents of the bepotastine besilate and the potential genotoxic impurities thereof can be effectively separated and measured; high sensitivity, specificity and repeatability are achieved; the measurement is not interfered by a solvent peak during detection, and a detection result is accurate and reliable, so that the method has an extremely important significance in realizing quality control for the bepotastine besilate and a preparation thereof.
Description
technical field [0001] The invention belongs to the field of analytical chemistry, and in particular relates to a method for separating and measuring bepotastine besilate and its potential genotoxic impurities by HPLC. Background technique [0002] Bepotastine is a non-sedating, highly selective histamine (H1) receptor inhibitor, which has a highly selective inhibitory effect on histamine H1 receptors, has no affinity for 5-HT2, α1, α2, and has no affinity for 5-HT2, α1, α2. Mast cells have a stabilizing effect, can inhibit the infiltration of eosinophils into the inflammatory site during allergic inflammation, and can inhibit the activation of eosinophils interleukin-5 (IL-5), leukotriene B4 (LTB4) and platelets Activating factor (PAF), reduces allergic inflammation. Pharmacodynamic tests show that: bepotastine can inhibit the skin reaction caused by histamine; in vitro tests can inhibit the contraction of guinea pig isolated smooth muscle caused by histamine, inhibit the ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): G01N30/74G01N30/06
CPCG01N30/06G01N30/74
Inventor 陈丽娜兰昌云唐朝军
Owner CHONGQING HUAPONT PHARMA
PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.
